Sartorius Stedim Biotech Proposes Unchanged Dividend Amidst New Board Nominations
Sartorius Stedim Biotech has proposed a status quo dividend of 0.69 euros per share for fiscal 2024, sparking questions about stagnation and investor satisfaction.
2 minutes to read